Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Virpax Pharmaceuticals, Inc. (VRPX)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 0.0 | 17.0 | 19.0 | 20.6 | 26.1 | 30.8 | 36.8 | 41.7 |
| Other current assets | 16.0 | 1.5 | 0.7 | 3.1 | 3.3 | 3.9 | 2.7 | 1.6 |
| Total current assets | 16.0 | 18.5 | 19.7 | 23.6 | 29.4 | 34.7 | 39.6 | 43.3 |
| Other fixed assets | 1.1 | 1.5 | 0.7 | 3.1 | 3.3 | | 2.7 | |
| Total assets | 16.0 | 18.5 | 19.7 | 23.6 | 29.4 | 34.7 | 39.6 | 43.3 |
| |
| Accrued expenses | | | 2.0 | | 0.0 | 0.0 | | 0.1 |
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other current liabilities | 3.6 | 3.3 | 1.1 | 4.2 | 2.5 | 2.2 | 2.1 | 1.7 |
| Total current liabilities | 3.6 | 3.3 | 3.1 | 4.2 | 2.5 | 2.2 | 2.1 | 1.8 |
| Total liabilities | 3.6 | 3.3 | 3.1 | 4.2 | 2.5 | 2.2 | 2.1 | 1.8 |
| |
| Shareholders' equity [+] | 12.3 | 15.2 | 16.6 | 19.4 | 26.9 | 32.6 | 37.5 | 41.5 |
| Paid-in capital | 61.3 | 61.1 | 60.9 | 60.8 | 60.6 | 60.4 | 60.2 | 60.0 |
| Retained earnings | -49.0 | -45.9 | -44.4 | -41.4 | -33.7 | -27.8 | -22.7 | -18.6 |
| Tangible shareholders' equity | 12.3 | 15.2 | 16.6 | 19.4 | 26.9 | 32.6 | 37.5 | 41.5 |
|